IPRIPR2022-00886Final Written Decision
Novartis Pharmaceuticals Corporationv.Shilpa Pharma, Inc.
IPR challenge of US 9266816.
Type
IPR
Filed
Apr 20, 2022
Instituted
Oct 26, 2022
Decided
Feb 3, 2026
Patent
Application
13635207
Inventor
Vimal Kumar Shrawat et al
Granted
Feb 23, 2016
01
Timeline
3 milestones
2022-04-20Petition filed
2022-10-26Institution
2023-09-29Terminated
02
Parties & counsel
Petitioner
Novartis Pharmaceuticals Corporation
Counsel
Love, Janeet al
Patent Owner
Shilpa Pharma, Inc.
Counsel
Boland, Market al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →